Wealthcreatures.com
1.42K subscribers
1.19K photos
48 videos
40 files
1.54K links
Visit us at www.wealthcreatures.com

Driven by Fundamentals and Leveraging Technicals.

All post are Only For Study & Educational Purpose.consult you Financial Advisor Before Investing or taking any position.
DISCLAIMER:We r Not SEBI REGISTERED ANALYST.
Download Telegram
TRIVENI ENG

CMP - 75.50

ADD BWT - 74 TO 75.50

POSSIBLE # 10% TO 15% UPMOVE

ONCE CLOSED AVOBE 80 NEW 52wk high possible in 15 to 30 days

S/L - 71
https://wealthcreatures.com/2020/03/30/mastek/

🎯MASTEK 🎯

BLASTING TO MAKE A NEW 52wk HIGH AGAIN

NO STOPPAGE

NEW 52wk HIGH AGAIN

1⃣0⃣0⃣0⃣ coming πŸ”œπŸ”œ

169 TO 794 DONE IN JUST 4.5 MONTHS

4.7x RETURNS TILL NOW

AS TOLD THIS WONT STOP

5X/6X coming πŸ”œπŸ”œπŸ”œπŸ”œ

CAN BE OUR SUPER MULTIBAGGERS 10x IN NXT FEW YEARS

CONVICTION & PATIENCE IS KEY
MASTEK LOCKED IN 10% UC
MIDCAP & SMALL CAP

READY FOR GOOD UPMOVE

WHY???
πŸ‘‡πŸ‘‡πŸ‘‡πŸ‘‡

🎯From January 2021, Multicap schemes to have 25% in Large cap, 25% in Midcap and 25% in Smallcap. Remaining 25% can be invested as per fund managers choice.
With Rs.146708 cr of Multicap AUM as on 31st august, there can be a good interest in midcap and small caps by these funds. Early to comment on anything else.

🎯Big positive for mid-small cap stocks and Quality midcap and smallcap which are doing well and valuation are reasonable Get Ready To see Big Upmove.


🎯Multi-cap funds have to invest 25% each in small and midcap stocks. Small cap cos can see inflow of 20-25k cr.Sudden shift in mandate can drive smallcap and midcap stocks to crazy levels.
Our Followers Conviction
πŸ’Ž OUR RECENT PERFORMANCE πŸ’Ž

AS ON 1⃣2⃣th AUGUST'20

🎯 NONE OF OUR INVESTMENT PICK GAVE NEGATIVE RETURNS & MANY STOCK GIVING RETURNS AS
HIGH 4⃣0⃣0⃣%

🎯 CHECK OUR WEBSITE & CHANNEL FOR RECO RATE AND HIGH MADE AFTER THAT & STILL ITS COUNTING

🎯 IF YOU ARE SATISFIED THAN DO SHARE WITH YOUR FRIENDS & RELATIVE.

βœ… Link TO JOIN ON TELEGRAM βœ…

t.me/wealthcreature

πŸ‘‰MASTEK 169 TO 799 (375%)

πŸ‘‰VISAKA INDS 94 TO 387 (310%)

πŸ‘‰IOL CHEMICAL 193 To 899 (365%)

πŸ‘‰AARTI DRUGS 770 TO 3719 (382%)

πŸ‘‰MANGALAM ORGANIC 120 TO 614 (410%)

πŸ‘‰SMS LIFESCIENCES 153 TO 490 (220%)

πŸ‘‰STERLING & WILSON 84 TO 289 (240%)

πŸ‘‰DEEPAK FERTLISER 72 TO 193 (170%)

πŸ‘‰AUROBINDO PHARMA 382 TO 967 (153%)

πŸ‘‰DELTA CORP 54 TO 123 (130%)

πŸ‘‰GIC RE 82 TO 169 (105%)

πŸ‘‰iBull HOUSING 154 TO 263 ( 70%)

πŸ‘‰DEEPAK NITRITE 430 TO 824 (91%)

πŸ‘‰STRIDES PHARMA 312 TO 692 (120%)

πŸ‘‰HESTER BIO 957 TO 1795 (87%)

πŸ‘‰BIOCON 290 TO 446 (54%)

πŸ‘‰CADILA HEALTHCARE 274 TO 411 (40%)

πŸ‘‰GM BREWERIES 280 TO 459 (64%)

πŸ‘‰SBI CARDS 501 TO 855 (70%)

πŸ‘‰POWER MECH 336 TO 556 (65%)

πŸ‘‰INDOBORAX 193 TO 454 (135%)

πŸ‘‰ MAGMA FINCORP 18.50 TO 43 (135%)

πŸ‘‰VINDHYA TELE 430 TO 982 (130%)

πŸ‘‰KEC INTL 177 TO 344 (95%)

πŸ‘‰GNFC 100 TO 232 (132%)


πŸ‘‰SHREYANS INDS 74 TO 99 (33%)


🎯 WE DONT GIVE UPDATE FOR 10% OR 20% PLAY ONLY FOR BIGGER RETURNS 2x/3x/5Γ—/10Γ—

🎯 EQUITY IS OUR PASSION

🎯 WEALTH CAN BE CREATED ONLY BY INVESTING & HOLDING WITH PATIENCE. BUYING RIGHT STOCK AT RIGHT TIME WITH CONVICTION
NIFTY ABOVE 11690
BULLS WOULD MAKE A STRONG COME BACK & CAN CROSS RECENT HIGH OF 11794
*Deepak Fertilisers & Petrochemicals*

Sets rights issue price at Rs 133 per share. The rights entitlement ratio has been set a 3 shares for every 20 shares held. The record day has been set as September 17.

The issue price is a 17.6% discount to Friday's closing price. The issue opens on September 28 and closes on October 12.
πŸ’Ž TOP API STOCK PICKS πŸ’Ž

WHICH CAN OUTPERFORM MARKETS

AARTI DRUGS
LAURUS LABS
SOLARA ACTIVE PHARMA
GRANULES
IOL CHEMICALS & PHARMA


FEW DATA ABT API STOCK


SOLARA ACTIVE PHARMA

MKT CAP# 3468 cr
TTM P/E 25x
TTM PAT #130 cr vs FY19 pat at 60 cr
Rs 50 eps in FY21e?
MF holding at 5.71% (SBI, DSP, UTI)

In next 2yrs we can see EPS jump in solara because Vizag plant contribution will start subjective to regulatory approval and we feel some tax holiday also for vizag possible and also low equity base.

LAURUS LAB

MKT CAP # 13483 cr
TTM P/E 32x
3 Years sales, pat growth >10%
Rs 65 EPS in FY21
MF holding at 4.15% (SBI, Kotak)

Laurus Lab with Debottlenecking which will be finished in FY21Q3 or Q4 and doubling the capacity of formulation plant by 2022 with growing CRAMS business, I won’t be surprised to see its EPS in three digits by 2023 .

GRANULES

MKT CAP # 8522 cr
TTM P/E 24x
3 Years sales, pat growth >20%
Management guidance + 25% growth
MF holding NIL
AARTI DRUGS

SUPPORT @2600

GETTING READY FOR BIG UPMOVE

RECORD DATE CAN BE ANNOUNCED IN NEXT 15 TO 20 DAYS

ONCE CROSSED 3000 On CBSL BIG UPMOVE COMING